Olympus Launches First HD Single-Channel Therapeutic Gastroscope for Advanced Diagnosis and Treatment of GI Tract

Olympus Launches First HD Single-Channel Therapeutic Gastroscope for Advanced
                     Diagnosis and Treatment of GI Tract

New Scope Allows Hospitals to Realize Cost Savings and Efficiencies Through
One-Scope Solution for Diagnosis and Therapy

PR Newswire

CENTER VALLEY, Pa., May 28, 2014

CENTER VALLEY, Pa., May 28, 2014 /PRNewswire/ -- Olympus, a global technology
leader in delivering innovative diagnostic and therapeutic solutions for
medical and surgical procedures, among other core businesses, announced today
the commercial availability of its 510(k) cleared, next-generation GIF-1TH190
gastrointestinal videoscope for endoscopy or endoscopic surgery use within the
upper digestive tract.

The GIF-1TH190 is the first one-channel therapeutic gastrointestinal
videoscope to offer HD observation capabilities and NBI in a new, slimmer
scope design, making it ideal for most upper GI procedures

As the first single-channel therapeutic gastroscope to offer both
high-definition (HD) and Narrow Band Imaging capabilities, the GIF-1TH190
provides physicians with the advanced resolution and enhanced imaging needed
for screening and diagnosis, along with a large 3.7 mm working channel for
therapeutic applications.

"Imaging is increasingly important as we advance our minimally invasive
techniques for resection of early neoplastic lesions," said Robert H. Hawes,
MD, attending endoscopist at Florida Hospital. "If you want to do therapy, you
must have optimal imaging. Using the same scope for imaging and therapy is
optimal. The new GIF-1TH190 will allow that."

Prior to the GIF-1TH190, HD technology was primarily used in the upper GI
tract for diagnostic functions. As physicians shifted from diagnosis to
therapy, they switched to a scope with lesser-quality visualization in favor
of a larger working channel. The GIF-1TH190 goes beyond the previous
technology to allow for excellence in visualization at the same time that
therapy is delivered. The decreased size of the imaging chip allows for a
narrower insertion tube, while the larger working channel allows for the
insertion of dilation balloons, ablation tools, coagulation probes and other
devices physicians may want to use.

The HD and electronically enhanced imaging in the GIF-1TH190 provides sharper
contours, more natural colors and greater resolving power for visualization of
fine details. The GIF-1TH190 also delivers enhanced Narrow Band Imaging (NBI).
NBI is a validated visualization tool for observing capillary and mucosal
structures, allowing better observation of dysphasia, metaplasia and
inflammation in patients with Barrett's esophagus.

According to Truven Health data, U.S. physicians performed more than 8.6
million upper endoscopy procedures in 2012^[i] in an effort to detect, prevent
or treat Barrett's esophagus, cancers, lesions and other disorders in the
upper digestive tract. Barrett's esophagus, commonly considered to be a
precancerous condition, is estimated to affect 1.6 to 6.8 percent of the
population.^[ii] Using HD NBI to target suspicious areas in Barrett's
esophagus patients can result in significantly fewer biopsies than white light
examination with the Seattle protocol^[iii].

Key features of the GIF-1TH190 include:

  oHDTV image quality: HD imaging delivers improved screening and diagnostic
    capabilities.
  oNarrow Band Imaging: HD NBI provides contrast, which may aid in the
    interpretation of mucosal morphology, vascular patterns, and blood vessel
    appearance in patients with Barrett's esophagus. It also provides nearly
    twice the viewable distance under NBI compared to previous-generation
    scopes.
  oSlim design: The 10.0 mm distal end diameter is 0.9 mm less than the
    scope's predecessor while maintaining a large 3.7 mm working channel.
  oDepth of field: The 2-100 mm depth of field allows close examination of
    the mucosa without the need for magnification.
  oWater jet: A forward water jet helps keep the mucosa clear during
    observation and treatment.
  oWaterproof one-touch connector: A new connector simplifies the effort
    required for setup; its fully submersible design eliminates the need for a
    water-resistant cap and minimizes the risk of fluid invasion.
  oEVIS EXERA III universal platform:  The scope is powered by an advanced
    imaging system, which works seamlessly across specialties to provide
    easier data management and cost efficiencies.

As part of the EVIS EXERA III system, the GIF-1TH190 offers tangible
improvements over its predecessor, including an advanced imaging unit, better
image processing, noise reduction and reduced halation.

"The GIF-1TH190 offers superb diagnostic capabilities in a therapeutic scope,"
said Luke Calcraft, President of the Medical Systems Group at Olympus
Corporation of the Americas. "This allows physicians to use just one
instrument to perform both tasks, creating procedural and cost efficiencies.
We are committed to helping our customers meet the triple aim of Affordable
Care by improving quality of care, decreasing costs and enhancing patient
satisfaction."

Olympus' GIF-1TH190 gastrointestinal videoscope was showcased at Digestive
Disease Week 2014 earlier this month in Chicago, IL. For more information,
please contact your Olympus representative, call 800-848-9024 or visit our
GIF-1TH190 web page.

About Olympus Medical Systems Group
Olympus Medical Systems Group, a division of global technology leader Olympus,
develops solutions for health care professionals that help improve clinical
outcomes, reduce overall costs and enhance quality of life for their patients.
By enabling less invasive procedures, innovative diagnostic and therapeutic
endoscopy, and early stage lung cancer evaluation and treatments, Olympus is
transforming the future of health care.

For more information, visit Olympus at medical.olympusamerica.com.

^[i]  Data for use in this study were supplied by Truven Health Analytics
Inc., Ann Arbor, Michigan ("Truven Health"). Any analysis, interpretation or
conclusion based on these data is solely that of the authors and Truven Health
disclaims responsibility for any such analysis, interpretation or conclusion.

^[ii]  "Barrett's Esophagus." NIH Publication No. 13–4546. National Digestive
Diseases Information Clearinghouse (NDDIC). Feb 2013. Web 12 May 2014.
http://digestive.niddk.nih.gov/ddiseases/pubs/barretts/#how

^[iii] Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol
can differentiate high-grade dysplasia fromearly adenocarcinoma in Barrett's
esophagus. Gastroenterology 1993; 105:40-50.

Photo - http://photos.prnewswire.com/prnh/20140528/91777

SOURCE Olympus Medical Systems Group

Website: http://medical.olympusamerica.com
Contact: Michael Levey, Olympus Corporation of the Americas, 484-896-5120,
michael.levey@olympus.com
 
Press spacebar to pause and continue. Press esc to stop.